In the BioHarmony Drug Report Database
Bezlotoxumab
Zinplava (bezlotoxumab) is an antibody pharmaceutical. Bezlotoxumab was first approved as Zinplava on 2016-10-21. It is used to treat clostridium infections in the USA. It has been approved in Europe to treat pseudomembranous enterocolitis.
Trade Name
|
Zinplava |
|---|---|
Common Name
|
bezlotoxumab |
ChEMBL ID
|
CHEMBL2108670 |
Indication
|
clostridium infections, pseudomembranous enterocolitis |
Drug Class
|
Monoclonal antibodies |
Image (chem structure or protein)
